Home
>
US Stocks
>
Axsome Therapeutics Inc
Axsome Therapeutics Inc
AXSM

Axsome Therapeutics Inc (AXSM)

$39.3969.35%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$39.96
Today Low/High
$38.91 / $40.76
52 Week Low/High
$20.5 / $90
Market Cap
$792.07M

Company Details

Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited treatment options. For the many people facing unsatisfactory treatments for CNS disorders, Axsome accelerates the invention and adoption of life-changing medicines. Axsome's core CNS product candidate portfolio includes five clinical-stage candidates, AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14. AXS-05 is being developed for major depressive disorder (MDD), Alzheimer's disease (AD) agitation, and as a treatment for smoking cessation. AXS-07 is being developed for the acute treatment of migraine. AXS-12 is being developed for the treatment of narcolepsy. AXS-14 is being developed for fibromyalgia. AXS-05, AXS-07, AXS-09, AXS-12, and AXS-14 are investigational drug products not approved by the FDA.
Organisation
Axsome Therapeutics Inc
Headquaters
New York, New York, US
Employees
60
Industry
Health Technology
CEO
Herriot Tabuteau

Discover more

Frequently Asked Questions

What is Axsome Therapeutics Inc (AXSM) share price today?

Can Indians buy Axsome Therapeutics Inc (AXSM) shares?

How can I buy Axsome Therapeutics Inc (AXSM) shares from India?

Can Fractional shares of Axsome Therapeutics Inc (AXSM) be purchased?

What are the documents required to start investing in Axsome Therapeutics Inc (AXSM) stocks?

We are a SEBI registered investement advisor